ArticlebioRxiv : the preprint server for biology2026
Genome-wide mapping of Cas9-induced sister chromatid exchange across single and over 200 genomic targets.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
CRISPR/Cas9-induced DNA double-strand breaks (DSBs) are widely used for genome engineering, yet their capacity to provoke sister chromatid exchange (SCE) and associated genome instability remains incompletely understood, in part because exchanges between identical sister chromatids leave no sequence change and are invisible to conventional whole-genome sequencing. Using sci-L3-Strand-seq, a scalable single-cell template-strand sequencing platform for genome-wide SCE mapping, we quantified strand-switch events following targeted Cas9 cleavage. A single Cas9 cut at a unique genomic locus led to strong local enrichment of SCE at the break site, reaching up to 41% in the same cell cycle and 17% in the subsequent division, indicating that DSB repair frequently engages non-local inter-sister repair. Extending the assay to 237 repetitive targets revealed mild and marginally statistically significant enrichment of on-target SCE across wild-type Cas9 and nickase variants (D10A and H840A). However, restricting analysis to a subset of cells with elevated SCE burden (>8 SCEs per cell) uncovered significant enrichment at programmed cut sites, suggesting that recombination at repetitive loci is conditionally engaged in highly recombinogenic cells. Reciprocal daughter-cell pair analysis further revealed large-scale structural alterations on chromosomes with induced SCEs and at SCE junctions, indicating that Cas9-induced SCEs do not universally reflect error-free homologous recombination. Disruption of DNA repair genes at the cut site, including LIG3, LIG4, XRCC1, and XRCC4, did not measurably alter SCE frequency per cell, consistent with delayed functional loss following editing and, in the case of essential genes such as LIG3, selection against disruptive alleles. Together, these findings demonstrate that Cas9-induced DSBs are potent local triggers of SCE at unique loci, while at repetitive regions SCE is more context-dependent and can be associated with structural alterations, highlighting the influence of lesion type and genomic context on recombination outcomes during genome editing.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.